Skip to content

MEDIDAT: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

MEDIDAT

BE 0428.034.076
NACE 46.460, Wholesale of pharmaceutical and medical goods
financial year 2024 compared with 2023filed annual accounts (NBB)
Net result for the year
-€25,951
2023 · €1,875-€27,826
Equity
€66,085
2023 · €92,036-€25,951
Cash
-
not filed
Balance sheet total
€84,610
2023 · €116,553-€31,943

Largest movements

2023 to 2024
Assets
  • Tangible fixed assets -€18,801

    down €18,801 (-40.3%), from €46,624 to €27,823

    of which Furniture and vehicles: -€13,846

  • Receivables within one year -€12,798

    down €12,798 (-21.3%), from €59,989 to €47,191

    of which Other amounts receivable: -€8,592

  • Financial fixed assets +€2,775

    new in 2024: €2,775

  • Stocks and contracts -€2,741

    down €2,741 (-31.1%), from €8,804 to €6,063

Equity and liabilities
  • Profit (loss) carried forward -€25,951

    new in 2024: -€25,951

  • Current portion of long-term debt -€4,694

    down €4,694 (-98.6%), from €4,759 to €64

  • Short-term financial debts -€4,182

    down €4,182 (-65.0%), from €6,439 to €2,256

  • Trade debts +€3,074

    up €3,074 (+26.9%), from €11,434 to €14,508

Income statement
  • Gross operating margin -€31,668

    down €31,668, from €26,599 to -€5,069

  • Taxes -€1,955

    down €1,955 (-91.5%), from €2,136 to €181

  • Other operating charges -€1,291

    down €1,291 (-25.1%), from €5,149 to €3,858

  • Financial income +€337

    up €337 (+13.3%), from €2,535 to €2,872

From the 2023 result to the 2024 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2023 €1,875
Gross operating margin -€31,668
Depreciation +€249
Other operating charges +€1,291
Financial income +€337
Financial charges +€11
Taxes +€1,955
Result 2024 -€25,951
raises the resultlowers the result

Derived cash bridge

cash 2023 to 2024

Cash or the result is not a separate line in both sets of accounts; the cash flow cannot be derived from them.

Every line side by side 42 lines
Line Code 2023 2024 Change %
Total assets 20/58 €116,553 €84,610 -€31,943 -27.4%
Fixed assets 21/28 €46,624 €30,598 -€16,026 -34.4%
Tangible fixed assets 22/27 €46,624 €27,823 -€18,801 -40.3%
Land and buildings 22 €21,165 €16,209 -€4,956 -23.4%
Furniture and vehicles 24 €25,459 €11,614 -€13,846 -54.4%
Financial fixed assets 28 - €2,775 +€2,775
Current assets 29/58 €69,929 €54,012 -€15,917 -22.8%
Stocks and contracts in progress 3 €8,804 €6,063 -€2,741 -31.1%
Stocks 30/36 €8,804 €6,063 -€2,741 -31.1%
Amounts receivable within one year 40/41 €59,989 €47,191 -€12,798 -21.3%
Trade receivables 40 €7,449 €3,243 -€4,206 -56.5%
Other amounts receivable 41 €52,540 €43,948 -€8,592 -16.4%
Deferred charges and accrued income 490/1 €1,136 €758 -€377 -33.2%
Total equity and liabilities 10/49 €116,553 €84,610 -€31,943 -27.4%
Equity 10/15 €92,036 €66,085 -€25,951 -28.2%
Contributions 10/11 €53,297 €53,297 = 0.0%
Reserves 13 €38,739 €38,739 = 0.0%
Non-distributable reserves 130/1 €1,951 €1,951 = 0.0%
Reserves not available under the articles 1311 €1,951 €1,951 = 0.0%
Distributable reserves 133 €36,788 €36,788 = 0.0%
Profit (loss) carried forward 14 - -€25,951 -€25,951
Amounts payable 17/49 €24,517 €18,525 -€5,992 -24.4%
Amounts payable within one year 42/48 €24,517 €18,525 -€5,992 -24.4%
Current portion of amounts payable after more than one year 42 €4,759 €64 -€4,694 -98.6%
Financial debts 43 €6,439 €2,256 -€4,182 -65.0%
Credit institutions 430/8 €6,439 €2,256 -€4,182 -65.0%
Trade debts 44 €11,434 €14,508 +€3,074 +26.9%
Suppliers 440/4 €11,434 €14,508 +€3,074 +26.9%
Taxes, remuneration and social security 45 €1,886 €1,697 -€189 -10.0%
Taxes 450/3 €1,886 €1,697 -€189 -10.0%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €19,050 €18,801 -€249 -1.3%
Other operating charges 640/8 €5,149 €3,858 -€1,291 -25.1%
Gross operating margin 9900 €26,599 -€5,069 -€31,668
Operating profit (loss) 9901 €2,400 -€27,729 -€30,129
Financial income 75/76B €2,535 €2,872 +€337 +13.3%
Recurring financial income 75 €2,535 €2,872 +€337 +13.3%
Financial charges 65/66B €924 €913 -€11 -1.2%
Recurring financial charges 65 €924 €913 -€11 -1.2%
Profit (loss) for the period before taxes 9903 €4,011 -€25,770 -€29,781
Income taxes 67/77 €2,136 €181 -€1,955 -91.5%
Profit (loss) for the period 9904 €1,875 -€25,951 -€27,826
Profit (loss) for the period to be appropriated 9905 €1,875 -€25,951 -€27,826

Source: filed annual accounts (NBB), financial years ended 31 December 2023 and 31 December 2024. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 16 October 2026 via checked.be.